These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6083935)

  • 21. Hypercalcemia and diffuse osteolytic lesions in the acute phase of chronic myelogenous leukemia. A possible relation between lymphoid transformation and hypercalcemia.
    Tricot G; Boogaerts MA; Broeckaert-Van Orshoven A; Criel A; Van Hoof A; Van den Berghe H
    Cancer; 1983 Sep; 52(5):841-5. PubMed ID: 6575858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone lesions in chronic granulocytic leukaemia.
    Martell RW; Myers HS; Jacobs P
    Br J Haematol; 1986 Jan; 62(1):31-5. PubMed ID: 3455819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meningeal leukaemia in the blastic phase of chronic granulocytic leukaemia.
    Van Bever H; Benoit Y; Delbeke MJ; Orye E
    Eur J Pediatr; 1985 Nov; 144(4):417-8. PubMed ID: 3865773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prognosis of children with chronic myeloid leukemia: a retrospective analysis of 75 patients].
    Creutzig U; Ritter J; Zimmermann M; Klingebiel T
    Klin Padiatr; 1996; 208(4):236-41. PubMed ID: 8926689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Adult form of chronic myelogenous leukemia in childhood--a retrospective analysis of 20 patients].
    Creutzig U; Brandeis W; Gerein V; Ritter J; Stollmann B; Kabisch H; Niethammer D; Schellong G
    Klin Padiatr; 1985; 197(3):203-6. PubMed ID: 3859702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Juvenile type of chronic myeloid leukaemia in a four year old boy.
    el Mauhoub M; Sudarshan G; Baloch R
    Klin Padiatr; 1988; 200(1):15-9. PubMed ID: 3285086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Painful lytic bone lesion in an adult with chronic myelogenous leukemia.
    Campbell E; Maldonado W; Suhrland G
    Cancer; 1975 May; 35(5):1354-6. PubMed ID: 1054619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The importance of scintimetry in the differential diagnosis of roentgenological areas of increased "translucence" in the skeleton of children (author's transl)].
    Benz G; Georgi P
    Rofo; 1979 Apr; 130(4):465-9. PubMed ID: 155603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autologous marrow transplantation for patients with chronic myeloid leukemia in accelerated or blastic phase: report of 14 cases.
    Lemonnier MP; Gorin NC; Laporte JP; Douay L; Lopez M; van den Akker J; Stachowiak J; David R; Pene F; Kantor G
    Exp Hematol; 1986 Aug; 14(7):654-8. PubMed ID: 3525203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A CML case of 3-year survival after a myeloid blastic crisis treated with VP therapy and steroid pulse therapy].
    Suemaru S; Hirakawa S; Yamamoto N; Kageyama J; Ota Z; Kitajima K; Sakamoto K; Kamura J
    Rinsho Ketsueki; 1986 Apr; 27(4):589-93. PubMed ID: 3461188
    [No Abstract]   [Full Text] [Related]  

  • 31. Piperazinedione plus total body irradiation: an alternative preparative regimen for allogeneic bone marrow transplantation in advanced phases of chronic myelogenous leukemia.
    Horwitz LJ; Kantarjian HM; Jagannath S; Keating MJ; McCredie KB; Spitzer G; Vellekoop L; Zander AR; Dicke KA
    Bone Marrow Transplant; 1989 Jan; 4(1):101-5. PubMed ID: 2647172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cause of death, survival, and prognostic factors in a series of 98 patients with chronic myeloid leukemia].
    Jonte F; Fernández-Fuertes F; Cecchini C; Luño E; Ordóñez A; Fernández C; Suárez P; Lausín A; Fernández J
    Sangre (Barc); 1992 Oct; 37(5):351-4. PubMed ID: 1293774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three-phase bone scanning in chronic myelogenous leukemia.
    Ginsberg HN; Swayne LC
    Clin Nucl Med; 1987 Oct; 12(10):823-4. PubMed ID: 3479290
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of CML with blastic crisis by the combination therapy of VP and low-dose Ara-C].
    Chou T; Wakabayashi M; Hayashi N; Arakawa M
    Rinsho Ketsueki; 1992 Sep; 33(9):1263-7. PubMed ID: 1433949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Destructive osteolytic bone lesions in chronic granulocytic leukemia.
    Crain SM; Choudhury AM; Molnar Z; Jablokow VR
    IMJ Ill Med J; 1982 Sep; 162(3):213-7. PubMed ID: 6129223
    [No Abstract]   [Full Text] [Related]  

  • 36. Osteolytic lesions in chronic myeloid leukaemia.
    Manoharan A; Phadke KP; Leyden MJ
    Aust N Z J Med; 1979 Feb; 9(1):87-8. PubMed ID: 287450
    [No Abstract]   [Full Text] [Related]  

  • 37. Primary Hodgkin's disease of bone.
    Cowie F; Benghiat A; Holgate C
    Clin Oncol (R Coll Radiol); 1991 Jul; 3(4):233-5. PubMed ID: 1931766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Busulphan and melphalan prior to autologous transplantation for myeloid malignancies.
    Cony-Makhoul P; Marit G; Boiron JM; Puntous M; Reiffers J
    Bone Marrow Transplant; 1995 Jul; 16(1):69-70. PubMed ID: 7581131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Complete cytogenetic response obtained with unrelated donor lymphocyte infusion for relapse of chronic myeloid leukemia in blastic crisis after allogeneic bone marrow transplantation].
    Fujimaki K; Maruta A; Yoshida M; Yamazaki E; Matsuzaki M; Fujisawa S; Kanamori H; Ishigatsubo Y
    Rinsho Ketsueki; 2001 Mar; 42(3):204-8. PubMed ID: 11345783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic and prognostic value of the terminal deoxynucleotidyl transferase (TdT) activity in treating the blastic phase (bp) of chronic granulocytic leukaemia (CGL).
    Rudzka E; Hołowiecki J; Bartnikowa W; Krawczyk M; Duraj M; Jarczok K; Hołowiecka B; Suhs M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(6):864-71. PubMed ID: 2419215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.